Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hall, Marcia
CORINTH, NCT04046133: Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus	Recruiting	1b	50	Europe	Pembrolizumab, Radiotherapy, Chemotherapy (Mytomycin or Mitomycin and Capecitabine)	Cardiff University	Anal Cancer Stage III A, Anal Cancer Stage III B	11/22	11/22
VALTIVE1, NCT04523116: Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors:	Recruiting	N/A	176	Europe		University of Manchester, Cancer Research UK, Centre for Trials Research, Cardiff University	Ovary Cancer	05/23	06/23
BriTROC-2, NCT05537844: Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma	Recruiting	N/A	250	Europe		Liz-Anne Lewsley, Ovarian Cancer Action	Ovarian Cancer, High Grade Serous Carcinoma, Carcinosarcoma, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, BRCA1 Mutation, BRCA2 Mutation	10/24	04/25